NAPSA and mucinous adenocarcinoma: Goldstein and Thomas and others have shown mucinous adenocarcinomas to be nonreactive for TTF1 and our study also demonstrates the similar trend.19Hence, in mucinous adenocarcinomas TTF1 should be avoided and Napsin A or any other alternative markers should be preferred whenever limited panel is applied.